International Alliance for Personalised Medicine shared on LinkedIn:
“The Virus Crossed the Ocean. Are We Any Better Prepared?
While many of us are enjoying the slower pace of August, science, healthcare and policy continue to move forward. And so does the latest edition of the IPM Brief.
This week’s issue takes readers on a journey across continents and centuries, following one common thread: how diseases, discoveries and innovation travel, and whether health systems are ready to respond.
From new evidence confirming how smallpox crossed the Atlantic with European colonisation, to the rapid expansion of next-generation sequencing into routine clinical care, from the promise of multi-cancer early detection to the way cancer treatments themselves reshape tumours, each story reminds us that scientific progress is never static.
But discovery alone is not enough.
Every breakthrough raises the same fundamental question: how do we ensure that knowledge becomes better care for patients?
In this edition, we also explore:
- Why public investment in science should deliver public benefit;
- The growing challenge of turning genomic innovation into equitable access;
- Why patients must remain at the centre of personalised medicine, not be reduced to their molecular profile;
- How international collaboration can shorten the path from approval to patient access.
At IAPM, we believe healthcare is not transformed by headlines alone. It changes when evidence informs policy, implementation follows innovation, and patients can benefit, wherever they live.
Issue 17 of the IPM Brief is now available. Subscribe to receive evidence-based insights on personalised medicine, healthcare policy and innovation directly in your inbox, twice every week.”
Other articles about International Alliance for Personalised Medicine on OncoDaily.